Impact of neoadjuvant chemotherapy on post-hepatectomy regeneration for patients with colorectal cancer liver metastasis - Systematic review and meta-analysis.

[1]  J. Søreide,et al.  Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  F. Tomassini,et al.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review , 2020, Updates in Surgery.

[3]  J. Geoghegan,et al.  The effect of preoperative chemotherapy on liver regeneration after portal vein embolization/ligation or liver resection in patients with colorectal liver metastasis: a systematic review protocol , 2020, Systematic Reviews.

[4]  A. Majeed,et al.  Liver regeneration and liver metastasis. , 2020, Seminars in cancer biology.

[5]  A. Kow.  Hepatic metastasis from colorectal cancer. , 2019, Journal of gastrointestinal oncology.

[6]  M. Fakih,et al.  Systemic treatment for metastatic colorectal cancer in the era of precision medicine , 2019, Journal of surgical oncology.

[7]  T. Pawlik,et al.  Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective? , 2017, Annals of surgery.

[8]  S. Shiraishi,et al.  Preoperative Chemotherapy on Functional Liver Regeneration for Colorectal Liver Metastases Assessed With 99mTc-GSA SPECT/CT Imaging , 2018, International Surgery.

[9]  T. Pawlik,et al.  The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample , 2018, Journal of Gastrointestinal Surgery.

[10]  K. Uchiyama,et al.  Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis , 2018, World Journal of Surgery.

[11]  T. Pawlik,et al.  Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency , 2017, Journal of clinical and translational hepatology.

[12]  T. Pawlik,et al.  Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis , 2018, World Journal of Surgery.

[13]  T. Pawlik,et al.  Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases , 2017, Journal of surgical oncology.

[14]  J. Shi,et al.  Experimental evaluation of liver regeneration patterns and liver function following ALPPS , 2017, BJS open.

[15]  M. Machado,et al.  Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy , 2017, Surgery.

[16]  F. Carli,et al.  Preoperative modifiable risk factors in colorectal surgery: an observational cohort study identifying the possible value of prehabilitation , 2017, Acta oncologica.

[17]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[18]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  W. Chapman,et al.  Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. , 2016, Journal of the American College of Surgeons.

[20]  M. Aljiffry,et al.  Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases , 2016, Journal of Surgical Oncology.

[21]  M. Büchler,et al.  Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. , 2015, Journal of the American College of Surgeons.

[22]  G. Spolverato,et al.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand? , 2015, Journal of Gastrointestinal Surgery.

[23]  T. Gruenberger,et al.  Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[25]  G. Poston,et al.  Controversies in the oncosurgical management of liver limited stage IV colorectal cancer. , 2014, Surgical oncology.

[26]  T. Hickish,et al.  Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. , 2014, The Lancet. Oncology.

[27]  T. Utsunomiya,et al.  Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy. , 2014, Anticancer research.

[28]  S. Truant,et al.  Volumetric Gain of the Liver after Major Hepatectomy in Obese Patients: A Case-Matched Study in 84 Patients , 2013, Annals of surgery.

[29]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[30]  Jianming Xu,et al.  Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  G. Wakabayashi,et al.  Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume , 2013, World Journal of Surgical Oncology.

[32]  C. Dejong,et al.  Influence of Preoperative Chemotherapy on CT Volumetric Liver Regeneration Following Right Hemihepatectomy , 2013, World Journal of Surgery.

[33]  S. Truant,et al.  Volumetric Analysis of Remnant Liver Regeneration After Major Hepatectomy in Bevacizumab-Treated Patients: A Case-Matched Study in 82 Patients , 2012, Annals of surgery.

[34]  T. Utsunomiya,et al.  The impact of bevacizumab on liver regeneration following hepatectomy in rats. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  P. Bachellier,et al.  Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization , 2011, Surgery Today.

[36]  E. O'Neill,et al.  Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro. , 2010, Investigative ophthalmology & visual science.

[37]  J. E. Lee,et al.  Effect of bevacizumab on strabismus surgery in rabbits. , 2010, Investigative ophthalmology & visual science.

[38]  M. Gönen,et al.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. , 2010, Journal of the American College of Surgeons.

[39]  J. Weitz,et al.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. , 2010, The Lancet. Oncology.

[40]  E. Abdalla,et al.  Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases , 2008, Annals of Surgical Oncology.

[41]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[42]  L. Ellis,et al.  Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases , 2007, Cancer.

[43]  H. Petrowsky,et al.  Strategies for safer liver surgery and partial liver transplantation. , 2007, The New England journal of medicine.

[44]  T. Pawlik,et al.  Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.

[45]  T. V. van Gulik,et al.  Severe Steatosis Increases Hepatocellular Injury and Impairs Liver Regeneration in a Rat Model of Partial Hepatectomy , 2007, Annals of surgery.

[46]  M. Ychou,et al.  Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. , 2006, European journal of cancer.

[47]  T. Pawlik,et al.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Frcsc Paul D. Greig MD,et al.  Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience , 2006, Annals of Surgical Oncology.

[49]  O. Farges,et al.  The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[50]  L. Ellis,et al.  Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  W. Hawkins,et al.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.

[52]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[53]  K. Tanikawa,et al.  Expression and Role of Vascular Endothelial Growth Factor in Liver Regeneration After Partial Hepatectomy in Rats , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  M. Borner.  Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer--too good to be true? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  H. Bismuth,et al.  Surgery of hepatic tumors. , 1993, Progress in liver diseases.